Published in Retina

Two Surgical Approaches: Non-Clearing Vitreous Hemorrhage (NCVH)

This is editorially independent content
6 min read

This article offers ophthalmologists surgical pearls for treating a non-clearing vitreous hemorrhage and two videos of surgeons breaking down these procedures.

Two Surgical Approaches: Non-Clearing Vitreous Hemorrhage (NCVH)
Non-clearing vitreous hemorrhage (NCVH) cases can present in various ways with different levels of severity. In some cases, you may know the underlying diagnosis, and the surgery can be fairly straightforward. Other times you may not know what caused the bleeding, and the surgery can be more of a mystery case. No matter the situation, following certain surgical principles can help ensure a good surgical outcome and minimize the risk of a complication.
This article will review tips for surgical procedures addressing NCVH and provide videos of anterior and posterior pars plana vitrectomies.

Surgical pearls for NCVH from a branch retinal vein occlusion

Michael Ammar, MD
  1. Prior to surgery: Be prepared for whatever may be hidden beneath the vitreous hemorrhage. Use all the preoperative information, exams, and imaging available to form an adaptable surgical plan. Try to have everything you may need available in the operating room.
  2. Vitrectomy: Vitrectomize only in areas of clear visualization. Depending on the degree of blood, visualization can be very poor. Stay where the cutter is illuminated and well-visualized and keep the cutter mouth pointed up towards you. As areas begin to clear, move towards them cautiously. It’s easy to get overzealous and chase the vitreous right into healthy retinal tissue or other structures and cause iatrogenic damage.
  3. Infusion: Watch the infusion; if the hemorrhage is dense enough, the cannula may not be visible and can be occludable. Also, watch the structural integrity of the globe, and if there is any concern that the infusion is poor or compromised, assess the line and increase the IOP to 60 if needed temporarily. Once the area around the cannula has been vitrectomized, this is typically no longer an issue.
  4. Shaving: Be very cautious with shaving. It is tempting and natural to want to remove as much blood as possible, but the closer you shave the vitreous base, the higher the risk of an iatrogenic break. A break in this setting can be obscured by blood and may lead to an iatrogenic detachment. This can significantly alter the postoperative course for the patient and potentially require a long-acting tamponade. There is nothing wrong with leaving some of the vitreous skirt behind, as patients will do great. Shave cautiously, and don’t get too aggressive.
  5. Reassess: When necessary, take a moment to pause and reassess. This is an important rule for any surgery, and it applies to NCVH cases as well. As the view clears, sometimes we see the underlying pathology for the first time. It’s important to take a moment and formulate the best plan for the patient now that new information has revealed itself.

Video of NCVH from a branch retinal vein occlusion

📚

Watch a video of the surgical procedure!

These videos are step-by-step breakdowns of surgeries performed to address NCVH.

Surgical pearls for a pars plana vitrectomy

Eric K. Chin, MD, David RP Almeida, MD, MBA, PhD, Harris Ahmed, DO, MPH
Preoperatively, I always remind patients that cataract surgery is an expectation and not a complication. Living in an area with mountains and high altitudes, I always bring up the possibility of needing a gas or oil tamponade, even if it is unlikely, based on B-scan ultrasound prior to surgery.
Intravitreal anti-VEGF therapy—while waiting for medical clearance—is a helpful adjunct that can regress culprit abnormal neovascular vessels. Sometimes medical clearance can linger for months, and once in a while, the vitreous hemorrhage will clear with injections.

During the pars plana vitrectomy

Intraoperatively, I have a low threshold for using diluted triamcinolone (50%) after a core vitrectomy is performed to ensure that a complete posterior vitreous detachment (PVD) is present and the hyaloid has been lifted and/or removed with the cutter. This will also aid in shaving the vitreous base.

Ensure that the panretinal photocoagulation (PRP) laser is complete— I like to surround the nerve and macula and extend the PRP laser to the ora with the aid of scleral depression.

Hemostasis from oozing neovascular vessels can be controlled by temporarily elevating the IOP or using an endo-diathermy probe to cauterize abnormal vessels.

After the pars plana vitrectomy

Post-operatively, it is not uncommon to have mild residual red blood cells lingering in the vitreous cavity. This can sometimes take a few weeks to resolve and reabsorb in a fluid-filled vitrectomized eye.
In cases where residual or recurrent vitreous hemorrhage lingers, I have a low threshold to reinject with monthly anti-VEGF therapy. Sometimes oozing can arise from neovascularization at the disc after the peeling of membranes, and there’s no better way to stop additional bleeding than with anti-VEGF therapy, in my opinion.

Vitrectomy tips for diabetic NCVH

The following video represents a straightforward case of pars plana vitrectomy for a non-clearing diabetic vitreous hemorrhage. When the vitreous hemorrhage is diffuse with poor vision, I often offer and discuss the option of surgery/vitrectomy to accelerate the potential improvement in vision. With the improved safety and efficiency of vitrectomy surgery, it is a valuable and viable option for many patients with baseline poor vision or chronic vision loss.

Video of pars plana vitrectomy

📚

Watch a video of the surgical procedure!

These videos are step-by-step breakdowns of surgeries performed to address NCVH.

Want more surgical videos? Check out the previous installment in this series: Scleral Buckle for Retinal Detachment: Three Surgical Approaches

Michael Ammar, MD
About Michael Ammar, MD

Michael Ammar, M.D., is a board-certified vitreoretinal surgeon and partner at Retina Consultants San Diego. He obtained his medical degree in Los Angeles at the University of Southern California where he received the Dean’s Recognition Award for clinical and surgical excellence each of his medical years. His achievements and accolades resulted in his induction into Alpha Omega Alpha, the nation’s highest honor society, and graduating Summa Cum Laude with the USC Highest Distinction Award. He continued his training with ophthalmology residency in the Ivy League at the University of Pennsylvania, Scheie Eye Institute. He then pursued a surgical retina fellowship at the top-ranked Wills Eye Hospital in Philadelphia.

At the Wills Eye Hospital, Dr. Ammar performed and taught thousands of procedures and surgeries for retinal conditions and complex ocular trauma. He has been involved in cutting-edge clinical trials and has authored numerous book chapters and studies. He has presented his work nationally and abroad. He has also served as a reviewer for multiple academic journals such as Retinal Cases and Brief Reports, American Journal of Ophthalmology, and RETINA.

Michael Ammar, MD
Eric K Chin, MD
About Eric K Chin, MD

Dr. Eric K Chin is a board-certified ophthalmologist in the Inland Empire of Southern California. He is a partner at Retina Consultants of Southern California, and an Assistant Professor at Loma Linda University and the Veterans Affair (VA) Hospital of Loma Linda. He is a graduate of University of California Berkeley with a bachelor’s of science degree in Bioengineering. Dr. Chin received his medical degree from the Chicago Medical School, completed his ophthalmology residency at the University of California Davis, and his surgical vitreoretinal fellowship at the University of Iowa. During his residency and fellowship, he was awarded several accolades for his teaching and research in imaging and novel treatments for various retinal diseases.

Eric K Chin, MD
David RP Almeida, MD, MBA, PhD
About David RP Almeida, MD, MBA, PhD

David Almeida, MD, MBA, PhD, is a vitreoretinal eye surgeon offering a unique voice that combines a passion for ophthalmology, vision for business innovation, and expertise in ophthalmic and biomedical research. He is President & CEO of Erie Retina Research and CASE X (Center for Advanced Surgical Exploration) in Pennsylvania. 

David RP Almeida, MD, MBA, PhD
Harris Ahmed DO, MPH
About Harris Ahmed DO, MPH

Harris Ahmed DO, MPH is a vitreoretinal surgery fellow physician at Weill Cornell. He is a leader in health policy, serving in national leadership positions in multiple organizations including the AMA, AOCOOHNS, and AOA. He has authored many publications and given lectures on public health advocacy and health policy, specializing in topics such as scope of practice, physician distribution, and medical education. He is currently serving on the board of Trustees for the California Academy of Eye Physicians and Surgeons.

Harris Ahmed DO, MPH
How would you rate the quality of this content?
Eyes On Eyecare Site Sponsors
Astellas LogoAstellas Logo